- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07604701
Examining the Efficacy of the Man Therapy Platform in Reducing Problematic Anger Among Military Service Members With and Without a TBI History
Examining the Efficacy of the Man Therapy Platform in Reducing Problematic Anger Among Military Service Members With and Without a TBI History: A Randomized Controlled Trial
The goal of this randomized controlled trial is to determine if an interactive digital solution, Man Therapy, reduces indices of problematic anger in male military service members who screen positive for problematic anger.
The man questions this study aims to answer are:
- Does Man Therapy reduce indices of problematic anger?
- Does Man Therapy reduce psychosocial correlates of anger?
Researchers will also examine if the effects of those aims differ based on a participant's history of a mild TBI, the mechanism of a primary mild TBI, and/or the number of mild TBIs.
Researchers will compare Man Therapy to a waitlist control. This will help determine if Man Therapy works better than no treatment.
Participants will:
- Complete a baseline survey
- Be randomized to intervention or waitlist control
- If randomized to intervention, participants will receive the intervention and complete a survey immediately after the intervention and at 1-, and 3-months following the intervention
- If randomized to waitlist control, participants complete surveys at 1-, and 3-months and have the opportunity to complete the intervention following the 3-month survey
Panoramica dello studio
Stato
Intervento / Trattamento
Descrizione dettagliata
Problematic anger is highly prevalent among military service members. Among service members, problematic anger prospectively predicts suicidal ideation, even after controlling for other psychiatric disorders. Existing approaches designed to reduce anger have not been shown to satisfactorily impact clinical outcomes across populations, and among service members receiving treatment for PTSD, anger is one of the few symptoms that persists even if a PTSD diagnosis subsides. Thus, there is a need to adapt existing problematic anger treatments for service members.
Man Therapy is an interactive digital solution that uses humor and straightforward language to circumvent traditional barriers to accessing mental health care. The aim of this study will evaluate the efficacy of the Man Therapy platform compared to waitlist control in reducing indices of problematic anger among male military service members with problematic anger. Participants will be randomized following the pre-intervention assessment. Participants randomized to receive Man Therapy will view the interactive digital solution in a single session. Assessments will occur pre-intervention, post-intervention, and at 1- and 3-month follow-ups. Waitlist controls will receive the intervention after the 3-month follow-up. The goal is to reduce indices of problematic anger and psychosocial correlates of anger.
Aim 1: To evaluate the efficacy of Man Therapy relative to waitlist controls in reducing indices of problematic anger among male military SMs who present with problematic anger (N = 226).
Hypothesis 1: Compared with waitlist controls at 1- and 3-month follow-ups, Man Therapy will result in lower levels of anger, as measured by the State-Trait Anger Expression Inventory-2 (STAXI-2) subscale of "State Anger (S-Anger)."
Objective 2: To evaluate the efficacy of Man Therapy relative to waitlist controls in reducing psychosocial correlates of anger (e.g., suicidal ideation, PTSD symptoms, poor interpersonal functioning) among male military SMs with problematic anger.
Hypothesis 2: Compared with waitlist control at 1- and 3-month follow-ups, Man Therapy will result in lower levels of (a) PTSD symptoms (PTSD Checklist for DSM-5 [PCL-5]), (b) suicidal ideation (Depressive Symptom Index-Suicidal Ideation [DSI-SS]34), and (c) poor interpersonal functioning (Interpersonal Needs Questionnaire-15 [INQ-15]).
Objective 3: To examine if the effects in Objectives 2 and 3 differ based on a participant's history of a mild TBI, the mechanism of primary mild TBI, and/or the number of mild TBIs.
Hypothesis 3: Compared with those without TBI, those with history of TBI will have higher levels of anger, as measured by the State-Trait Anger Expression Inventory-2 (STAXI-2), higher levels of PTSD symptoms (PTSD Checklist for DSM-5 [PCL-5]), more severe suicidal ideation (Depressive Symptom Index-Suicidal Ideation [DSI-SS]), and poorer interpersonal functioning (Interpersonal Needs Questionnaire-15 [INQ-15]).
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: Dr. Ian Stanley PhD
- Numero di telefono: 720-848-6777
- Email: emed_ManTherapy@cuanschutz.edu
Backup dei contatti dello studio
- Nome: Julia Finn, MPH
- Numero di telefono: 720-848-6777
- Email: emed_ManTherapy@cuanschutz.edu
Luoghi di studio
-
-
Colorado
-
Colorado Springs, Colorado, Stati Uniti, 80913
- Fort Carson
-
Contatto:
- Julia Finn, MPH
- Numero di telefono: 720-848-6777
- Email: emed_stanleylab@cuanschutz.edu
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Adulto
- Adulto più anziano
Accetta volontari sani
Descrizione
Inclusion Criteria:
- Military service member
- Identify as male
- Aged 18+ years
- Positive problematic anger screen (DAR-3 >8)
- Ability to read, write, and speak English
Exclusion Criteria:
- Active psychosis or acute mania necessitating clinical intervention
- Acute thoughts of self- or other-harm necessitating imminent clinical intervention (e.g., hospitalization)
- Unable to provide informed consent
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Trattamento
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Man Therapy
Behavioral: Man Therapy Participants randomized to this arm will be offered Man Therapy, which is an interactive digital solution designed to reduce problematic anger. |
Man Therapy is an interactive digital solution that uses humor and straightforward language to circumvent traditional barriers to accessing mental health care, such as stigma.
A core Man Therapy module focuses on anger, helping recipients to understand its causes and associated mitigating and potentiating factors, as well as teaching recipients accessible, easy-to-implement anger mitigation strategies, such as cognitive retraining and paced breathing.
Participants will be given a list of content regarding anger to view and interact with in the Man Therapy website and encourages to explore the website further.
They will then review and interact with materials for at least 20 minutes and up to 45 minutes in a single session.
|
|
Nessun intervento: Waitlist Control
Waitlist Control: Waitlist controls will be offered Man Therapy after the 3-month follow-up assessment. Using a waitlist control facilitates a comparison between the immediate effects of the Man Therapy intervention on problematic anger and co-occurring conditions and the natural progression of the conditions without intervention, as well as providing the control group with access to the intervention. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
State Anger (S-Anger) Subscale as Measured by State-Trait Anger Expression Inventory-2 (STAXI-2)
Lasso di tempo: From enrollment to the completion of a 3-month follow-up assessment.
|
The STAXI-2 is a 57-item self-report measure of various dimensions of problematic anger.
The STAXI-2 can generate scores on the following six subscales: state anger (S-Anger), trait anger (T-Anger), anger expression-out (AX-O), anger expression-in (AX-I), anger control-out (AC-O), and anger control-in (AC-I).
Respondents rate each item on a 4-point scale from "almost never" to "almost always."
Scores are summed within each subscale and higher scores represent more problematic anger.
|
From enrollment to the completion of a 3-month follow-up assessment.
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
PTSD symptoms (PTSD Checklist for DSM-5 [PCL-5])
Lasso di tempo: From enrollment to the completion of the 3-month follow-up assessment.
|
The PCL-5 is a 20-item self-report measure of PTSD symptoms per DSM-5 diagnostic criteria.
Participants rate how much they have been bothered by each symptom over the past month, using a 5-point scale (0 =Not at all, 1 = A little bit, 2 = Moderately, 3 = Quite a bit, 4 = Extremely).
Responses are summed to generate a total score and symptom cluster scores corresponding to DSM-5 diagnostic criteria (i.e., intrusions, avoidance, negative alterations in cognitions and mood, hyperarousal); higher scores reflect more severe PTSD symptomatology.
|
From enrollment to the completion of the 3-month follow-up assessment.
|
|
Suicidal Ideation (Depressive Symptom Index-Suicidal Ideation [DSI-SS])
Lasso di tempo: From enrollment to the completion of the 3-month follow-up assessment.
|
The DSI-SS is a 4-item self-report measure of the severity of suicidal ideation occurring over the past 2 weeks.
Respondents rate each item on a 4-point scale ranging from 0 to 3 (e.g., Item 1: 0 = I do not have thoughts of killing myself; 1 = Sometimes I have thoughts of killing myself; 2 = Most of the time I have thoughts of killing myself; 3 = I always have thoughts of killing myself).
Responses are summed to generate a total score ranging from 0 to 12; higher scores indicate more severe suicidal ideation.
|
From enrollment to the completion of the 3-month follow-up assessment.
|
|
Poor Interpersonal Functioning (Interpersonal Needs Questionnaire-15 [INQ-15])
Lasso di tempo: From enrollment to the completion of a 3-month follow-up assessment.
|
The INQ-15 is a 15-item self-report measure of poor interpersonal functioning, including thwarted belongingness and perceived burdensomeness.
These constructs, collectively assessing social disconnectedness, are proposed by the interpersonal theory of suicide to lead to the development of suicidal desire.
Respondents rate each item (e.g., "These days, I rarely interact with people who care about me") on a 7-point scale ranging from 1 to 7 (e.g., 1 = Not at all true for me, 4 = Somewhat true for me, 7 = Very true for me).
Scores are summed (range: 15-105) and higher scores indicate worse interpersonal functioning.
|
From enrollment to the completion of a 3-month follow-up assessment.
|
Collaboratori e investigatori
Sponsor
Collaboratori
Investigatori
- Investigatore principale: Ian Stanley, PhD, University of Colorado Anschutz School of Medicine
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- 25-1301
- HT9425-25-1-0484 (Altro numero di sovvenzione/finanziamento: Department of Defense)
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Man Therapy
-
Tan Tock Seng HospitalARTICARES Pte LtdCompletato
-
Tan Tock Seng HospitalReclutamento
-
Tan Tock Seng HospitalNational Medical Research Council (NMRC), SingaporeCompletato
-
Royal Marsden NHS Foundation TrustImperial College London; Institute of Cancer Research, United Kingdom; RM Partners...ReclutamentoFumare | Alcolismo | Malattie urologiche | Ipertensione | Diabete | Cancro alla prostata | Cancro alla vescica | Cancro renale | Cancro urologico | Problema di salute mentale | Cancro al testicoloRegno Unito
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)Attivo, non reclutante
-
Karadeniz Technical UniversityCompletatoEmodialisi | Solitudine | Felicità | Adattamento | Terapia assistita da animali | SintomoTacchino
-
University of AmsterdamGgz Oost Brabant; Academic Center for Trauma and Personality; Arkin Mental Health...Iscrizione su invitoDisturbo borderline di personalitàOlanda
-
University of Applied Sciences and Arts of Southern...CompletatoAllenamento di resistenza | Studio sui partecipanti saniSvizzera
-
Zealand University HospitalUniversity of Copenhagen; Technical University of Denmark; OptoCeuticsCompletatoMalattia di AlzheimerDanimarca
-
Muş Alparslan UniversityCompletatoImpotenza appresa | Confronto socialeTacchino